Sodium Hydroxide → HCID 67314192, compound
Reaction equation
[Cl:1][C:2]1[C:3]2[N:4]([C:8]([C:11]3[C:16]([C:17]#[N:18])=[CH:15][N:14]=[C:13]([NH:19][C@H:20]([C:22]4[CH:27]=[CH:26][C:25]([CH:28]([OH:41])[CH:29]5[CH2:34][CH2:33][N:32](C(=O)C(F)(F)F)[CH2:31][CH2:30]5)=[CH:24][CH:23]=4)[CH3:21])[N:12]=3)=[CH:9][N:10]=2)[CH:5]=[CH:6][CH:7]=1.[OH-].[Na+]>O1CCCC1.CO>[Cl:1][C:2]1[C:3]2[N:4]([C:8]([C:11]3[C:16]([C:17]#[N:18])=[CH:15][N:14]=[C:13]([NH:19][C@H:20]([C:22]4[CH:27]=[CH:26][C:25]([CH:28]([OH:41])[CH:29]5[CH2:34][CH2:33][NH:32][CH2:31][CH2:30]5)=[CH:24][CH:23]=4)[CH3:21])[N:12]=3)=[CH:9][N:10]=2)[CH:5]=[CH:6][CH:7]=1Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 50 °C
Procedure
237 mg of the compound [37-3] was dissolved in a mixed solvent of 3 mL of tetrahydrofuran and 1 mL of methanol, then 163 μL of 5N aqueous solution of sodium hydroxide was added thereto, and the mixture was stirred for 5 hours at 50° C. After standing to cool, the reaction solution was concentrated under reduced pressure, and the resulting residue was purified by silica gel column chromatography (eluent: chloroform/methanol=95/5-93/7), to obtain 156 mg of 4-(8-chloroimidazo[1,2-a]pyridin-3-yl)-2-[((1S)-1-{4-[hydroxy(piperidin-4-yl)methyl]phenyl}ethyl)amino]pyrimidine-5-carbonitrile [374] (hereinafter, referred to as the compound [374]).
Workup
- temperatureto cool
- concentrationthe reaction solution was concentrated under reduced pressure
- customthe resulting residue was purified by silica gel column chromatography (eluent: chloroform/methanol=95/5-93/7)
Sources & evidence
- ORD record
- ord-9f978bd0519d4395ba840b2fade54735
- Source dataset
- uspto-grants-2011_07
- Patent number
- US07977336B2
Reaction notes
Loading…